Triazolopyrazine
AssigneeBoehringer Ingelheim International GmbH
InventorsHarald Engelhardt, Davide Gianni, Christian Smethurst
Life of this patent
Estimating the term…
Abstract
Disclosed are compounds of the formula (I) wherein the groups R1 to R3 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament.
Claims66
A compound of the formula:
A pharmaceutically acceptable salt of a compound of the formula:
A compound of the formula:
A pharmaceutically acceptable salt of a compound of the formula:
A compound of the formula:
A pharmaceutically acceptable salt of a compound of the formula:
A compound of the formula:
A pharmaceutically acceptable salt of a compound of the formula:
A compound of the formula:
A pharmaceutically acceptable salt of a compound of the formula:
A compound of the formula:
A pharmaceutically acceptable salt of a compound of the formula:
A compound of the formula:
A pharmaceutically acceptable salt of a compound of the formula:
A compound of the formula:
A pharmaceutically acceptable salt of a compound of the formula:
A compound of the formula:
A pharmaceutically acceptable salt of a compound of the formula:
A compound of the formula:
A pharmaceutically acceptable salt of a compound of the formula:
A compound of the formula:
A pharmaceutically acceptable salt of a compound of the formula:
Dependencies are inferred from the claim text.